Drive Medical has completed its largest acquisition to date, acquiring DeVilbiss Healthcare, effective July 2, 2015.
Accreditation Commission for Health Care’s (ACHC) Sleep Accreditation program recently received acceptance by PacificSource Health Plans. The approval by PacificSource will allow ACHC-accredited sleep providers in Oregon, Idaho, Washington, and Montana to access the network.
Researchers with the Parkinson Progression Marker Initiative (PPMI) have found that dopamine transporter (DAT) scanning can be an effective tool in identifying prodromal Parkinson’s disease (PD) in REM sleep behavior disorder (RBD), according to a study released at the 19th International Congress of Parkinson’s Disease and Movement Disorders.
Casper, a sleep startup that launched with a mattress, has closed a $55 million Series B investment round. The new investment was led by Institutional Venture Partners (IVP), and includes Leonardo DiCaprio, Tobey Maguire, Adam Levine, Scooter Braun, and Pritzker Group Venture Capital.
Sorin SpA, a global medical device company that focuses on the treatment of cardiovascular diseases, and Cyberonics Inc, a medical device company with core expertise in neuromodulation, unveiled "LivaNova" as the name of their combined company, effective at the close of their proposed merger.
Researchers led by Toru Takumi at the Riken Brain Science Institute in Japan have discovered a key mechanism underlying how animals keep track of the seasons. The study, published in Proceedings of the National Academy of Sciences, shows how circadian clock machinery in the brain encodes seasonal changes in daylight duration through GABA activity along with changes in the amount of chloride located inside certain neurons.
North Shore InnoVentures, a technology incubator and business accelerator, announced that, along with two of its other portfolio companies, sleep improvement wearable maker InsomniSolv Inc received a Milestone Achievement Program grants from the Massachusetts Life Sciences Center.
blue light symposium
At the recent New York Blue Light Symposium, the International Blue Light Society outlined three measures to counter consequences of artificial illumination faced by the global community.
Researchers from the University of Leicester have suggested that a "thermosensory" gene could be responsible for changes in behavior in different climates.
narcolepsy scholarship
Project Sleep, a non-profit organization dedicated to raising awareness about sleep health and sleep disorders, has selected the recipients of the 2015 Jack & Julie Narcolepsy Scholarship.
New expert recommendations for the prevention and treatment of augmentation in patients suffering from restless legs syndrome (RLS) list Horizant (gabapentin enacarbil) as a first-line therapy with a lower risk of developing augmentation.
OSA University, a dental sleep medicine team training online education center, is hosting a 1-hour webinar on CPAP Awareness, scheduled for June 30, 2015 at 6:00 PM CDT.
Nihon Kohden senior manager Dr Takuo Aoyagi has received the 2015 Institute of Electrical and Electronics Engineers (IEEE) Medal for Innovations in Healthcare Technology.
Narcolepsy Network’s annual conference brings people with narcolepsy (PWNs) and their supporters together to hear from some of the world's leading narcolepsy specialists and to share experiences with one another.
When rats rest, their brains simulate journeys to a desired future such as a tasty treat, finds University College London (UCL) research funded by the Wellcome Trust and Royal Society.
The brain responds differently to stimuli when asleep than when awake, and it is not clear what brain changes happen during sleep.
Using a pair of glasses that shine light into the wearer’s eyes, a pilot study led by University at Buffalo sleep researcher Grace Dean is attempting to solve insomnia among lung cancer patients. The researchers are examining if the rays can trigger neurotransmitters in the brain and reset participants’ sleep cycles.
The European Food Safety Authority (EFSA) has published its scientific opinion on the safety of caffeine, in which it estimates acute and daily intakes that raise no safety concerns for the general healthy population.
A group of biotechnology executives and medical doctors have formed the Coma Research Institute, a non-profit organization dedicated to providing education, research, and therapeutic possibilities to patients and families suffering from disorders of consciousness.
New research reveals although 80% of physically active adults say they desire 8 or more hours of sleep per night, only 41% percent actually get it.